Background: Atrial fibrillation (AF) is the most common chronic cardiac arrhythmia. Predicting the risk of complications, or associated increases in healthcare costs, among AF patients is important for effective health care management.
INTRODUCTION
Atrial fibrillation (AF) is the most common chronic cardiac arrhythmia (irregular heart rhythm). AF patients are at considerably elevated risk of stroke and other cardiovascular complications [1] , and AF also constitutes a risk factor for elevated all-cause mortality [2] . Predicting deterioration of health status is important for planning patient care and for effective health care management, as is the development of simple risk scoring algorithms that can be used by administrators in allocating resources. It is advantageous for routine use by managers that such a risk score be readily calculated using routine administrative healthcare data. It is also advantageous to effective health care administration that the costs of health care are considered as an aspect of broadly conceived health risk.
The present study accordingly considers methods for predicting the risk of deteriorating health status among AF patients using administrative data on Medicare Beneficiaries in the US. The focus is on upward transition between consumption classes (i.e. shifts to increased healthcare costs) during a single calendar year, 2008. Using the consumption class methodology of Caballero et al. [3] , patients are grouped into four consumption clusters: crisis consumers, heavy consumers, moderate consumers, and light/low consumers. Specifically the focus is on transition from low or light use (at end 2007) to moderate, heavy or crisis use (by end 2008). Data for the analysis are obtained from the Beneficiary Annual Summary File Data, which contains details of demographic status, service utilization, and history of chronic conditions for Medicare patients in the US.
The methodology has two aspects: regression to predict risk of transition to higher health consumption, and subsequent translation of the regression findings into a simplified risk scoring algorithm. The regression includes a latent morbidity index, contextual geographic factors (e.g. metropolitan residence, neighbourhood poverty), treatment (Warfarin) adherence and baseline consumption level. The regression is bivariate since as well as considering transition (or not) to higher cost levels, mortality as a possible subsequent or alternative outcome within the annual follow up period is also considered.
A number of risk scoring algorithms predict risk of complications or hospitalisation among AF patients [4] [5] [6] , encapsulating the results of more complex regression findings. The most widely used scores summarise patient risk in terms of medical conditions, possibly adding age as an additional influence, as in the CHADS 2 score [7] , or age and sex as in the CHA 2 DS 2 -VASC score [8] . These two scores do not adjust for ethnicity, treatment or prior health care usage. The present paper proposes a risk score including current health care costs (consumption category), ethnic group, and Warfarin adherence, as these were found relevant (in the regression) to predicting increased health consumption. [10, 11] , so that total risk is
METHODS

In
Appendix 1 sets out details of the indicators and predictors used in the study.
The outcome frame of reference is extended to include mortality between end 2007 and end 2008 (y 2i =1 for death, y 2i =0 otherwise). The mortality outcome provides additional information relevant to measuring patient morbidity (higher morbidity subjects are more likely to die earlier), so latent morbidity M i is shared across the two outcomes, namely
It is assumed that the latent variable M i in (1.3) and (2.2) is normal with mean zero X i and unknown variance M 2 . All reflective indicators are binary, so with Bern(p) denoting a Bernoulli density with probability p, one has
For scale identification, the loadings k (k=2,..,K) are taken as unknown, but 1 =1 [9] . For location identifiability, the X variables omit an intercept.
The impact of Warfarin adherence is assumed to vary by year of age. So with ages denoted a (=65,66,…,84,85+), the treatment effect in (1.3) consists of random effects a following a second order random walk evolution
where is an unknown precision parameter.
RESULTS
Regression Models
Two models are analysed, in order to show the benefit of a bivariate model: model 1 is the full bivariate response model, whereas model 2 considers change in consumption y 1i as a univariate response only. A Bayesian estimation and inference approach uses the BUGS software [12] . Thus Normal N(0,100) priors are assumed for unknown fixed effect parameters, while precisions (inverse variances) are assigned gamma priors with shape 1 and index 0.01. For the ordinal regression thresholds the re-parameterisation
is adopted, with the parameters taken as unconstrained normal with N(0,100) priors. Inferences are based on the second halves of two chain runs of 20000 iterations with convergence assessed using Gelman-Rubin statistics [13] .
Model fit is assessed using the Deviance Information Criterion [14] , and in terms of accurately predicting transition status. The latter is represented by a binary indicator s i , with s i =1 if a patient makes an upward cost transition (if y 1i 2), while s i =0 if a patient remains in low-light use throughout 2008. The area under the receiver operating curve (AUC) is often used to measure predictive success [4] , but in view of potential drawbacks [15, 16] , also considered is comparative sensitivity at a set false positive rate [17, 18] . For example, Pepe et al. [19] mention sensitivity at low false positive rates (e.g. FPR=0.2) is typically of interest. Table 1 shows a lower DIC, and higher AUC, for the full bivariate model 1. Model 1 also has a significantly higher sensitivity at a set FPR of 0.2. Table 2 shows parameter summaries for this model, except for Warfarin adherence, the impact of which is represented graphically (Figure 1 ).
Panel C of Table 2 shows that all K=7 reflective indicators are relevant to defining morbidity. The highest loadings are for heart failure, ischaemic heart disease, and inpatient spell. The parameters (representing formative influences) show increased age, black and Hispanic ethnicity are most significantly associated with elevated morbidity. There is also a gender effect, albeit less pronounced, with females at lower risk.
Regression effects for consumption transition and mortality are in panels A and B of Table 2 . These show strong morbidity effects on both outcomes, with coefficients highly significant. Baseline consumption is only significant for upward consumption transition, which is less likely to occur for patients classed as low users at end 2007 (with 95% interval for 1 from -0.58 to -0.50). Upward consumption transition is higher in metropolitan areas, and lower in the West region. Both effects may reflect differences between rural and urban hospital access, access to specialist care, etc.
The nonlinear treatment (Warfarin adherence) effect in reducing upward consumption transition is strongest at ages between 67 and 77. This is apparent from Figure 1 , which plots the estimated a parameters (posterior means and 95% credible intervals).
Predictive Risk Scoring
Translating statistical results into simple scoring algorithms is an area of on-going research [20] , and we Scores are assigned as follows: a score of 0 if the relative transition ratio (the ratio comparing averaged modelled transition probability to that in the reference group) is between 1 and 1.1, a score of 1 for transition ratios between 1.1 and 1.25, a score of 2 for transition ratios between 1.25 and 1.5, and a score of 3 for transition ratios over 1.5. Scores are specific to destination (moderate, heavy, critical consumption). Table 3 summarises relative transition ratios and scores for predictors where effects are significant enough to produce at least one relative transition ratio exceeding 1.1. For example, effects of gender, region and ZIP poverty are not large enough to be included.
Mirroring the largest loadings on morbidity indicators in Table 2 , it can be seen from Table 3 that heart failure and IHD have the largest relative transition ratios (comparing patients with these conditions to patients without such conditions). Similarly, the strong age gradient apparent in the coefficient 3 is reflected in the large relative transition ratios at ages 85+ in Table 3 . These ratios represent chances of moving to higher consumption for patients aged 85 and over as compared to patients aged 65-69. High scores also apply for patients in the light use consumption class at end 2007 as compared to the low use class. To illustrate how risk scores predict actual transitions, consider moves to heavy consumption. Table 4 and Figure 2 show observed transition behaviour at different scores. In predictive risk studies, thresholds are often assigned to distinguish low, intermediate and elevated risk. Table 4 accordingly also shows actual transition rates to heavy consumption for scores under 3, between 3 and 9, and over 10: respectively 5.4%, 10% and 16.1%. Figure 2 shows how actual transition rates to heavy consumption increase monotonically with the risk score.
The AUC and sensitivity at a FPR of 0.2 for the risk scores were evaluated for moves to heavy consumption, and compared with those obtained using the CHADS 2 score. The outcome here is relatively heterogeneous, namely deterioration in health resulting in increased health costs (usually from hospitalisation), rather than a single diagnosis. Hence AUC statistics are relatively low (Table 5) , though comparable to those reported by Hobbs et al. [4] and Philbin and DiSalvo [21] . Table 5 denotes the risk scores based on models of the present study as CC-Risk scores (CC for consumption class). The AUC for the CC-Risk score, namely 0.623 with 95% interval 0.616 to 0.630, is significantly above that of the CHADS 2 score, as is the sensitivity at an FPR of 0.2.
DISCUSSION
As compared to previous studies, the present study has detected a wider range of significant influences on increases in morbidity among AF patients. Such influences are relevant to future work on risk scoring algorithms for assessing worsening health status among cardiovascular patients. It has confirmed other studies in finding the morbidity risk among AF patients is related to age and comorbidities [7] . Existing risk scores (e.g. CHADS2, CHA2DS2-VASC) include these variables. However, the existing study also finds significant ethnic effects on increased health consumption, and shows improved risk score performance if ethnicity is included. Previous evidence The present study also confirms the effect of anticoagulant (Warfarin) therapy in reducing progression to increased costs, though not for very old patients. This confirms findings that such therapy reduces the risk of cardiovascular complications [23] . Atrial fibrillation is in itself a risk factor for excess morbidity and all-cause mortality [2, 24] , so if the condition is not managed with anti-coagulants, this may affect transitions to higher health spend categories (mainly hospitalisations) for a range of conditions, including non-cardiovascular conditions.
In line with the social model of health, the present study finds evidence that contextual factors may affect changes in morbidity status [25] [26] . In particular transition to higher cost (usually due to hospitalisation) is higher in metropolitan areas, and lower in the West region (which includes sparsely populated rural areas). Access to hospital care suitable for critical or complex conditions may be lower in rural areas; for example, rural hospitals in the US are smaller than their urban counterparts [27, 28] , and geographic access issues include longer travel distances and lack of reliable transportation [29] .
The present study benefits from a large sample size, and extensive information on pre-existing morbidity and service use. It focusses on health care spend as an indicator of morbidity, so contributing to a "longitudinal understanding of the resource burden" involved in the management of AF [30] . However, possible caveats to the analysis are the absence of information on personal or household income, which may affect access to care. A related possible drawback is absence of direct information on the quality of primary and community care preceding transition to higher costs, usually due to hospitalisation. Effective primary care can help reduce avoidable hospitalisations [31] .
CONCLUSION
The analysis here seeks to demonstrate the potential of administrative patient databases for predicting risks of transition to increased health spend categories. A bivariate regression model including information on comorbidities, service use history, patient demography, baseline consumption and residential context has been estimated.
A risk scoring algorithm for predicting transition to higher consumption levels is then set out, including the most significant risk factors from the regression: in addition to age and comorbidities (as included in CHADS 2 ), baseline consumption category, ethnic group, metropolitan residence and Warfarin adherence are significant influences that contribute to defining a risk score. For moves to heavy consumption in particular, actual proportions of patients making the transition increase monotonically with the risk score (see Figure 2) .
The risk scores in this application reflect the particular pattern of transition considered, namely from low or light use in 2007 to a higher level of health consumption a year later. Other types of transition may be considered, for example from low, light or moderate use combined to heavy or critical use. It would be expected that baseline consumption class level would again be important in any resulting risk scoring procedure. The treatment variable T i is an indicator of Warfarin adherence: AF patients are considered to be receiving warfarin if they had three or more prothrombin test claims in the year ending 2007 [32] .
APPENDIX 1 INDICATORS AND PREDICTORS
Contextual variables (C i ) are poverty rate in ZIP Tract (micro-area) of residence (C 1i , log transform of percent poverty rate), metropolitan or non-metropolitan area of residence (C 2i =1 for metro areas, C 2i =0 for nonmetro), and broad region (C 3i ) with four categories: 1=North East (reference), 2=mid-West, 3=South, and 4=West.
